Jiangxi Fushine Pharmaceutical Co., Ltd. (SHE:300497)
China flag China · Delayed Price · Currency is CNY
13.20
+0.01 (0.08%)
Nov 17, 2026, 3:04 PM CST

SHE:300497 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash & Equivalents
536.65482.98695.35729.37978.031,272
Trading Asset Securities
0.610.952.192.1949.74150.76
Cash & Short-Term Investments
537.26483.93697.54731.561,0281,423
Cash Growth
-15.35%-30.62%-4.65%-28.82%-27.79%-15.88%
Accounts Receivable
1,058533.29498.16572.92552.49376.21
Other Receivables
27.5347.3553.85128.3178.2180.01
Receivables
1,085580.64552.01701.23630.71456.22
Inventory
408.11379.93421.05434.68553.69416.15
Other Current Assets
26.0616.8410.429.9717.1115.97
Total Current Assets
2,0571,4611,6811,8772,2292,312
Property, Plant & Equipment
2,2292,2902,2672,3312,2011,857
Long-Term Investments
107.67271.31255.9271.27271.42133.02
Goodwill
----1.152.22
Other Intangible Assets
296.33287.85235241.07249.71256.32
Long-Term Deferred Tax Assets
39.2134.837.2629.3728.4927.54
Other Long-Term Assets
88.4659.6960.9569.1378.7990.82
Total Assets
4,8184,4054,5374,8195,0604,678

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Accounts Payable
421.27348.04603.37581.93656.67517.05
Accrued Expenses
15.5536.7144.0544.5242.451.97
Short-Term Debt
691.39571.5556.4549.83366.74615.18
Current Portion of Long-Term Debt
58.3270.02311.7878.787.9633.5
Current Income Taxes Payable
74.250.060.050.828.7113.89
Current Unearned Revenue
1.652.432.723.41.421.82
Other Current Liabilities
93.4940.4925.4626.32174.96126.56
Total Current Liabilities
1,3561,2691,5441,2861,2591,360
Long-Term Debt
716.71809.46736.48998.261,043353
Long-Term Unearned Revenue
125.74123.9777.6762.3962.0350.3
Long-Term Deferred Tax Liabilities
1.791.861.962.056.273.92
Total Liabilities
2,2342,2052,3602,3482,3701,767

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Common Stock
538.65538.65550550550550
Additional Paid-In Capital
1,2521,2471,3811,4141,4081,406
Retained Earnings
766.38353.75408.78680.88881.681,023
Treasury Stock
---174.86-174.86-174.86-105.11
Comprehensive Income & Other
7.4544.3315.4514.316.896.08
Total Common Equity
2,5642,1842,1802,4852,6812,880
Minority Interest
19.7916.38-3.54-14.068.431.1
Shareholders' Equity
2,5842,2002,1772,4712,6902,911
Total Liabilities & Equity
4,8184,4054,5374,8195,0604,678

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Total Debt
1,5001,6511,6051,6271,4181,002
Net Cash (Debt)
-962.74-1,167-907.13-895.31-389.97421.54
Net Cash Growth
------66.26%
Net Cash Per Share
-1.72-2.12-1.70-1.65-0.720.78
Filing Date Shares Outstanding
538.65538.65538.65538.65538.65538.65
Total Common Shares Outstanding
538.65538.65538.65538.65538.65543.13
Working Capital
700.7192.09137.2591.84970.42951.59
Book Value Per Share
4.764.054.054.614.985.30
Tangible Book Value
2,2681,8961,9452,2442,4302,622
Tangible Book Value Per Share
4.213.523.614.174.514.83
Buildings
-1,030936.67836.72712.09471.86
Machinery
-1,7731,6411,4231,232851.39
Construction In Progress
-428.95457.86695.78736.4922.19